Literature DB >> 20219542

Diagnostic tool based on an HTLV-1-Tax expression system in eukaryotic cells using a poxvirus vector.

Jaqueline Gontijo de Souza1, Flávio Guimarães da Fonseca, Olindo Assis Martins-Filho, Andrea Teixeira-Carvalho, Camila Pacheco Silveira Martins, Luciana Debortoli Carvalho, Jordana Grazziela Alves Coelho-Dos-Reis, Edel Figueiredo Barbosa-Stancioli.   

Abstract

Human T-lymphotropic virus 1 (HTLV-1) induces an immune-mediated inflammatory disease affecting the nervous system that eventually is accompanied by ocular, rheumatic and dermatologic manifestations (HTLV-1 associated myelopathy/tropical spastic paraparesis, or HAM/TSP). Proviral load and HTLV-1 protein expression, mainly of Tax, is correlated with disease progression and induction of host-virus equilibrium breakdown that, reportedly, involves the presence of Tax-specific cytotoxic T lymphocytes (CTL), T regulatory cells and anti-Tax antibodies. Based on knowledge of anti-Tax antibodies as markers of disease progression, the objectives of this study were both to design an infection/transfection system using the Vaccinia virus and a tax-encoding plasmid for the expression of Tax protein as well as to use this cell support to evaluate anti-Tax IgG by flow cytometry. The flow cytometry assay was standardized using pooled sera from each test group (negative, asymptomatic and HAM/TSP patients). The HAM/TSP group presented higher IgG anti-Tax reactivity (above 70%) than the asymptomatic group (nearly 40% reactivity). The data indicate that the infection/transfection system is useful for assessing Tax expression. This is a promising assay for use as a diagnostic tool to detect IgG anti-Tax and monitor HTLV-1 infected individuals. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20219542     DOI: 10.1016/j.jviromet.2010.02.021

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  2 in total

1.  Multi-Epitope Protein as a Tool of Serological Diagnostic Development for HTLV-1 and HTLV-2 Infections.

Authors:  Gabriela de Melo Franco; Anderson Santos da Rocha; Laura Jorge Cox; Danielle Soares de Oliveira Daian E Silva; Débora Marques da Silveira E Santos; Marina Lobato Martins; Luis Claudio Romanelli; Ricardo Ishak; Antonio C R Vallinoto; Maria Rosa Q Bomfim; Adele Caterino-de-Araujo; Jordana G A Coelho-Dos-Reis; Flávio Guimarães da Fonseca; Edel Figueiredo Barbosa-Stancioli
Journal:  Front Public Health       Date:  2022-05-23

2.  First Description of Seronegative HTLV-1 Carriers in Argentina.

Authors:  Sandra Gallego; María C Frutos; Sebastián Blanco; Gonzalo Castro; Marcos Balangero; David Elías Panigo; Arnaldo Mangeaud; Carlos Remondegui; Anderson Santos Rocha; Gabriela Melo Franco; Marina Lobato Martins; Edel Figueiredo Barbosa-Stancioli; Silvia Nates
Journal:  Am J Trop Med Hyg       Date:  2020-04       Impact factor: 2.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.